glyburide has been researched along with glipizide in 185 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 42 (22.70) | 18.7374 |
| 1990's | 59 (31.89) | 18.2507 |
| 2000's | 37 (20.00) | 29.6817 |
| 2010's | 39 (21.08) | 24.3611 |
| 2020's | 8 (4.32) | 2.80 |
| Authors | Studies |
|---|---|
| Gehlert, DR; Krushinski, JH; Mais, DE; Robertson, DW; Schober, DA; Thompson, DC | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Barton, P; Luker, T; Wenlock, MC | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Melander, A; Wåhlin-Boll, E | 2 |
| Balant, L | 1 |
| Blohmé, G; Waldenström, J | 1 |
| Abdel-Hay, MM; Ghanem, MH; Guirgis, FK | 1 |
| Gotfredsen, CF | 1 |
| Codaccioni, JL; Fontaine, G | 1 |
| Ceretti, AP; Emanueli, A; Losi, S; Orsini, G | 1 |
| Müller, WE; Wollert, U | 1 |
| Brunová, E | 1 |
| Balant, L; Fabre, J; Zahnd, GR | 1 |
| Alric, R; Loubatières, AL; Loubatieres-Mariani, MM; Ribes, G; Sorial, G; Tarasco, A | 1 |
| Alric, R; Lignon, F; Loubatières, A; Manteghetti, M; Puech, R | 1 |
| Madhavan, R; Sankaran, JR; Seshasaianam, C; Seshiah, V; Shanker, R; Sundaram, A; Venkataraman, S | 1 |
| Carter, BL; Helling, DK; McCormick, WC; Noyes, MA; Ramirez, R | 1 |
| Gwilt, M; Henderson, CG; Orme, J; Rourke, JD | 2 |
| Bird, DM; Cameron, DP; Ma, A; McIntyre, HD; Patterson, CA | 1 |
| Aguilar-Bryan, L; Bryan, J; Nelson, DA | 1 |
| Lazdunski, M; Schaeffer, P | 1 |
| Brodows, RG | 1 |
| Harrower, AD | 2 |
| Bemis, KG; Ertel, PJ; Robertson, DW; Steinberg, MI; Wiest, SA; Zimmerman, KM | 1 |
| Brown, TJ; Raeburn, D | 1 |
| Gackenheimer, SL; Gehlert, DR; Mais, DE; Robertson, DW | 1 |
| Kidd, GS; McDermott, MT; Simcic, KJ; White, JC | 1 |
| Feng, JG; Shi, MZ; Zheng, JJ | 1 |
| Aranyi, Z; Ballagi-Pordány, G; Koltai, MZ; Köszeghy, A; Pogátsa, G | 1 |
| Antal, EJ; Jaber, LA; Komanicky, P; Wenzloff, NJ | 1 |
| Huupponen, R; Karvonen, I; Rytömaa, K; Sotaniemi, EA; Vierimaa, E; Vuoti, MJ | 1 |
| Boutagy, JS; Shenfield, GM; Webb, C | 1 |
| Dash, RJ; Khandekar, S; Sethi, BK | 1 |
| Harrower, AD; Wong, C | 1 |
| Reckless, JP; Simpson, HC; Stirling, CA; Sturley, R | 1 |
| Lenzen, S; Männer, K; Panten, U; Trube, G; Zünkler, BJ | 1 |
| Schmitt, JK | 1 |
| Wilson, C | 1 |
| Morrison, AD; Shank, WA | 1 |
| Kure, J | 1 |
| Pollet, RJ; Rogers, BJ; Standaert, ML | 1 |
| DeFronzo, RA; Groop, L; Groop, PH; Luzi, L; Melander, A; Ratheiser, K; Simonson, DC | 1 |
| Boyd, AE; Gaines, KL; Hamilton, S | 1 |
| Adamson, U; Lins, PE; Lundblad, S; Persson-Trotzig, E | 1 |
| Borisova, AM; Georgieva, R; Koev, D; Taneva, T | 1 |
| Kuhn, T | 1 |
| Groop, L; Salo, S | 1 |
| Lenzen, S; Panten, U; Schwanstecher, M; Wallasch, A | 1 |
| Kilo, C | 1 |
| Arner, P; Bolinder, J; Ostman, J | 1 |
| Gerich, JE | 1 |
| Pearson, JG | 1 |
| Fyhrqvist, F; Groop, L; Groop, PH; Melander, A; Tolppanen, EM; Tötterman, KJ; Wåhlin-Boll, E | 1 |
| Baker, DE; Campbell, RK | 1 |
| Hellman, B; Sehlin, J; Täljedal, IB | 1 |
| Ahrén, B; Scherstén, B | 1 |
| Delawter, DE; Moss, JM | 1 |
| Chadwick, T; Harkness, J; Hartog, M; Paisey, RB | 1 |
| Loubatieres-Mariani, MM | 1 |
| Melander, A; Sartor, G; Scherstén, B; Wåhlin-Boll, E | 2 |
| Groop, L; Harno, K | 1 |
| Chow, CC; Cockram, CS; Sorensen, JP; Tsang, LW | 1 |
| Akkan, AG; Malaisse, WJ; Sener, A | 1 |
| Balabolkin, MI; Maksumova, MA; Orekhov, AN; Slavina, ES; Sobenin, IA | 1 |
| Bachmann, C; Chudziak, F; Löser, S; Panten, U; Schwanstecher, M | 1 |
| Elliott, BD; Johnson, R; Langer, O; Prihoda, T; Schenker, S | 1 |
| Birkeland, KI; Furuseth, K; Melander, A; Mowinckel, P; Vaaler, S | 1 |
| Nielsen-Kudsk, JE; Thirstrup, S | 1 |
| Amoroso, S; Bernardi, H; De Weille, JR; Epelbaum, J; Fosset, M; Lazdunski, M; Mourre, C; Slama, A | 1 |
| Chen, H; Duckworth, WC; Hamel, FG; Siford, G | 1 |
| Miller, JL; Rose, LI; Salman, K; Shulman, LH | 1 |
| Jaber, LA; Lewis, NJ; Neale, AV; Slaughter, RL | 1 |
| Hong, KW; Kwon, YJ; Lee, WS; Rhim, BY; Yu, SS | 1 |
| Ammälä, C; Berggren, PO; Bertorello, AM; Bokvist, K; Chibalin, A; Deeney, JT; Eliasson, L; Flatt, PR; Gäbel, J; Gromada, J; Larsson, O; Lindström, P; Renström, E; Rhodes, CJ; Rorsman, P | 1 |
| Ferguson, JE; Jacob, G; Landers, JP; Lawson, GM; Machacek, D; Núñez, M; Oda, RP | 1 |
| Gross, AS; Rieutord, A; Shenfield, GM; Stupans, I | 1 |
| Grenhoff, J; Johnson, SW | 1 |
| Selvaag, E; Thune, P | 1 |
| Kivistö, KT; Laine, K; Lehto, P; Neuvonen, PJ | 1 |
| Selvaag, E | 1 |
| Banerjee, A; Cain, BS; Cleveland, JC; Harken, AH; Meldrum, DR | 1 |
| Abenhaim, L; Monette, J; van Staa, T | 1 |
| Anderson, BD; Anderson, DL; Fenn, J; Gorman, SE; Krenzelok, EP; Muir, SJ; Rodgers, GC; Rose, SR; Spiller, HA; Villalobos, D | 1 |
| Landers, JP; Lawson, GM; Oda, RP; Roche, ME | 1 |
| Anderson, D; Briscoe, TA; Cooper, GS; Usifo, OS | 1 |
| Aubin, R; Lajeunesse, D; Lapointe, JY; Moreau, R | 1 |
| Luo, M; O'Brien, RC | 1 |
| Burge, MR; Fischette, C; Qualls, CR; Schade, DS; Schmitz-Fiorentino, K | 1 |
| Bernardi, G; Federici, M; Guatteo, E; Knöpfel, T; Mercuri, NB; Siniscalchi, A | 1 |
| Shorr, RI | 1 |
| Bernabei, R; Carbonin, P; Gambassi, G | 1 |
| Nadel, HL | 1 |
| Bataille, D; Blache, P; Gros, L; Salazar, G; Virsolvy, A | 1 |
| André, P | 1 |
| Brioni, JD; Gopalakrishnan, M; Miller, TR; Molinari, EJ; Monteggia, LM; Scott, VE; Sullivan, JP; Taber, RD; Whiteaker, KL | 1 |
| Ersöz, B; Girgin, FK; Menteş, G; Sözmen, EY; Tüzün, S | 1 |
| Courtois, P; Herbaut, C; Malaisse, WJ; Sener, A; Turc, A | 1 |
| Chugh, SN; Kakkar, R; Kharb, S; Sharma, A; Singh, GP | 1 |
| Gomis, R; Jones, NP; Patwardhan, RN; Squatrito, S; Wolffenbuttel, BH | 1 |
| Brioni, JD; Gopalakrishnan, M; Molinari, EJ; Monteggia, LM; Roch, JM; Scott, VE; Shieh, CC; Sullivan, JP; Whiteaker, KL | 1 |
| Bryer-Ash, M; Bush, A; Fisher, JN; Kaminska, E; Kitabchi, AE; Pitts, K; Sherman, A | 1 |
| Galli Kienle, M; Magni, F; Marazzini, L; Monti, L; Pereira, S | 1 |
| Eisenhofer, G; Harvey-White, J; He, LP; Hrycyna, C; Kopin, IJ; Lamensdorf, I; Nechushtan, A; Rojas, E; Tjurmina, O | 1 |
| de Smet, PA; Fischer, HR | 1 |
| Chan, JC; Cockram, CS; Critchley, JA; Hallengren, B; Jönsson, A; Melander, A; Rydberg, T; Vaaler, S | 1 |
| Backman, JT; Kivistö, KT; Neuvonen, M; Neuvonen, PJ; Niemi, M | 1 |
| Gottsäter, M; Lindberg, G; Lindwall, K; Melander, A; Olsson, J; Tisell, A | 1 |
| Cozma, LS; Dunseath, GJ; Langendorg, KW; Luzio, SD; Owens, DR; Pieber, T | 1 |
| Bussing, R; Gende, A | 1 |
| Argüelles, CF; Granados-Soto, V; Ortiz, MI | 1 |
| Mutalik, S; Udupa, N | 2 |
| Aronson, D; Burger, AJ; Mittleman, MA | 1 |
| Rochester, CD; Samuel, J | 1 |
| Bell, CF; Botteman, MF; Braunstein, SN; Devine, ST; Ramsdell, JW; Stephens, JM | 1 |
| Aburuz, S; McElnay, J; Millership, J | 1 |
| Debska, G; Kunz, WS; Skalska, J; Szewczyk, A | 1 |
| Ambrose, PJ; Briggs, GG; Donat, DJ; Feig, DS; Klein, J; Koren, G; Kraemer, JM; Moskovitz, DN; Nageotte, M; Padilla, G; Wan, S | 1 |
| Boettner, WA; Flynn, DM; Gernhardt, SS; Knight, DR; Levy, CB; Plowchalk, DR; Smith, AH; Soeller, WC; Tracey, WR; Treadway, JL; Wisniecki, P | 1 |
| Choudhury, H; Harisudhan, T; Mullangi, R; Srinivas, NR; Venkatesh, P | 1 |
| Jin, SH; Li, ZR; Shi, YQ; Yao, J | 1 |
| Krishnarajah, G; Lyu, R; Mavros, P; Vexiau, P; Yin, D | 1 |
| Mogensen, CE; Sadikot, SM | 1 |
| Djokanovic, N; Finkelstein, Y; Garcia-Bournissen, F; Glatstein, MM; Koren, G | 1 |
| Ee, JW; Kwon, SW; Lee, J; Lee, WJ; Park, JH; Shaodong, J | 1 |
| Arrigain, S; Atreja, A; Jain, A; Kattan, MW; Pantalone, KM; Wells, BJ; Yu, C; Zimmerman, RS | 2 |
| Bartley, EP; Hurren, KM; O'Neill, JL; Ronis, DL | 1 |
| Bilker, WB; Brensinger, CM; Hennessy, S; Schelleman, H; Wan, F | 1 |
| Heikkilä, P; Huupponen, R; Laine, K; Tirkkonen, T | 1 |
| Aguilera, E; Fasano, CJ; Heard, K; O'Malley, GF; Rowden, AK | 1 |
| Chan, JC; Chow, CC; Ko, GT; Kong, AP; Luk, AO; Ma, RC; Ng, VW; Ozaki, R; So, WY; Tong, PC; Yang, X; Yu, LW | 1 |
| Andersson, C; Gislason, GH; Hansen, PR; Jørgensen, CH; Køber, L; Mérie, C; Norgaard, ML; Olesen, JB; Schmiegelow, M; Sørensen, R; Torp-Pedersen, C; Vaag, A; Weeke, P | 1 |
| Burns, BD; Levine, M; Lovecchio, F; Pizon, AF; Riley, BD; Ruha, AM; Thomas, SH | 1 |
| Abdelmoneim, AS; Brocks, DR; Hasenbank, SE; Light, PE; Seubert, JM; Simpson, SH | 1 |
| Cantrell, M; Egge, JA; Shaw, RF; Skoff, RA; Waterbury, NV | 1 |
| Cui, G; McCarty, NA; Song, B; Turki, HW | 1 |
| Arrigain, S; Atreja, A; Jain, A; Kattan, MW; Nutter, B; Pantalone, KM; Wells, BJ; Yu, C; Zimmerman, RS | 1 |
| Coley, KC; Deusenberry, CM; Donihi, AC; Korytkowski, MT | 1 |
| Binz, TM; Neels, H; Schneider, S; Villani, N | 1 |
| AbuKhader, MM; Alqtaishat, S; Khanfar, MA; Taha, MO | 1 |
| Boyko, EJ; Floyd, JS; Forsberg, CW; Moore, K; Riley, K; Smith, NL; Wheeler, S | 1 |
| Bilker, WB; Brensinger, CM; Flockhart, DA; Han, X; Hennessy, S; Li, L; Quinney, SK; Schelleman, H | 1 |
| Jung, JS; Kim, CH; Kim, SJ; Kim, SS; Lim, SM; Park, SH; Sim, YB; Suh, HW | 1 |
| Goodwin, JS; Holmes, HM; Kuo, YF; Raji, MA; Tan, A | 1 |
| Goodwin, JS; Kuo, YF; Lin, YL; Parekh, TM; Raji, M; Tan, A | 1 |
| Andersson, C; Fosbøl, EL; Gislason, G; Køber, L; Mogensen, UM; Scheller, NM; Schramm, TK; Torp-Pedersen, C; Vaag, A | 1 |
| Bilker, WB; Brensinger, CM; Cardillo, S; Flockhart, DA; Flory, JH; Gagne, JJ; Han, X; Hennessy, S; Leonard, CE | 1 |
| Bilker, WB; Brensinger, CM; Chiang, C; Han, X; Hennessy, S; Leonard, CE; Li, L | 1 |
| Bergström, CAS; Edueng, K; Larsson, P; Mahlin, D | 1 |
| Archdeacon, P; Axtman, S; Carnahan, RM; Cavagnaro, E; Chrischilles, EA; Fuller, C; Gagne, JJ; Hampp, C; Hennessy, S; Iyer, A; Leonard, CE; Panozzo, CA; Toh, S; Wang, SV; Woodworth, TS; Zhou, M | 1 |
| Abdel-Kader, K; Greevy, RA; Griffin, MR; Horner, J; Hung, AM; Ikizler, TA; Matheny, ME; Parr, SK; Perkins, AM; Roumie, CL; Siew, ED; Speroff, T; Wilson, OD | 1 |
| Ahmed, T; Punde, R; Sahu, R; Sangana, R; Subudhi, BB | 1 |
| Aquilante, CL; Bilker, WB; Boudreau, DM; Brensinger, CM; Deo, R; Flory, JH; Gagne, JJ; Hennessy, S; Leonard, CE; Mangaali, MJ | 1 |
| Cordiner, RLM; Pearson, ER | 1 |
| Huang, HK; Yeh, JI | 1 |
| Campillo, NE; García-Pérez, CA; Haupt, VJ; Herrera-Mayorga, V; Juárez-Saldivar, A; Reyes-Espinosa, F; Rivera, G; Saavedra, E; Salentin, S; Schroeder, M; Vázquez, C; Villalobos-Rocha, JC | 1 |
| Bilker, WB; Brensinger, CM; Dawwas, GK; Dhopeshwarkar, N; Flory, JH; Gagne, JJ; Hennessy, S; Leonard, CE; Soprano, SE | 1 |
| Chiriac, FL; Iancu, VI; Radu, GL; Scutariu, RE | 1 |
| Bilker, WB; Brensinger, CM; Flory, JH; Hee Nam, Y; Hennessy, S; Leonard, CE | 1 |
| Khasipo, AZ; Sagandira, CR; Watts, P | 1 |
| Berry, SD; Hayes, KN; Munshi, MN; Riester, MR; Zullo, AR | 1 |
| Gayakvad, B; Kothari, C; Patel, C; Patel, R; Solanki, R; Wadhwana, P | 1 |
| Jannetto, PJ; Langman, LJ | 1 |
12 review(s) available for glyburide and glipizide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
Topics: Animals; Chlorpropamide; Dose-Response Relationship, Drug; Glipizide; Glyburide; Half-Life; Humans; Hypoglycemic Agents; Kinetics; Structure-Activity Relationship; Sulfonylurea Compounds; Tolbutamide | 1978 |
[Glipizide a new oral antidiabetic agent (comprehensive review)].
Topics: Animals; Blood Glucose; Chemical Phenomena; Chemistry; Diabetes Mellitus; Dogs; Drug Evaluation; Glipizide; Glyburide; Humans; Insulin; Insulin Secretion; Sulfonylurea Compounds | 1976 |
Oral sulfonylureas for the treatment of type II diabetes: an update.
Topics: Administration, Oral; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Glipizide; Glyburide; Humans; Insulin Resistance; Kinetics; Liver; Nausea; Patient Education as Topic; Sulfonylurea Compounds | 1986 |
The second generation oral sulfonylureas: glyburide and glipizide.
Topics: Administration, Oral; Drug Interactions; Glipizide; Glyburide; Humans; Sulfonylurea Compounds | 1988 |
Sulfonylureas in the treatment of diabetes mellitus--1985.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glipizide; Glyburide; Humans; Hypoglycemia; Insulin; Pancreas; Sulfonylurea Compounds | 1985 |
Pharmacological and molecular characterization of ATP-sensitive K+ channels in the TE671 human medulloblastoma cell line.
Topics: Adenosine Triphosphate; Animals; Barbiturates; Cells, Cultured; Cromakalim; Fluorescent Dyes; Fluorometry; Glipizide; Glyburide; Humans; Insulinoma; Isoxazoles; Medulloblastoma; Membrane Potentials; Muscle, Smooth; Parasympatholytics; Potassium Channels; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 1999 |
[Timing of administration of sulfonyl urea derivatives].
Topics: Biological Availability; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Tolbutamide | 2000 |
Combination agents for diabetes.
Topics: Adult; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
Use of hypoglycemic drugs during lactation.
Topics: Administration, Oral; Breast Feeding; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Infant, Newborn; Lactation; Maternal Welfare; Milk, Human; Pregnancy; Pregnancy in Diabetics; Risk Assessment; Sulfonylurea Compounds | 2009 |
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohexanes; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Isoindoles; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nateglinide; Phenylalanine; Piperidines; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Risk Factors; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide | 2012 |
Reflections on the sulphonylurea story: A drug class at risk of extinction or a drug class worth reviving?
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glucagon-Like Peptide-1 Receptor; Glyburide; History, 20th Century; History, 21st Century; Humans; Hypoglycemic Agents; Insulin Secretion; Insulin-Secreting Cells; Metformin; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Treatment Failure | 2019 |
28 trial(s) available for glyburide and glipizide
| Article | Year |
|---|---|
Glibenclamide and glipizide in maturity onset diabetes. A double-blind cross-over study.
Topics: Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind Method; Female; Glipizide; Glyburide; Humans; Insulin; Lipids; Male; Middle Aged; Placebos; Random Allocation; Sulfonylurea Compounds | 1979 |
A controlled study of the hypoglycemic and insulinopoietic effect of glipizide and glibenclamide in non-diabetic human subjects.
Topics: Adult; Blood Glucose; Clinical Trials as Topic; Female; Glipizide; Glyburide; Humans; Insulin; Middle Aged; Sulfonylurea Compounds; Time Factors | 1975 |
Evaluation of glipizide and glyburide in a health maintenance organization.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Costs; Evaluation Studies as Topic; Female; Glipizide; Glyburide; Health Maintenance Organizations; Humans; Male; Middle Aged; Retrospective Studies; Texas | 1992 |
Chronic sulfonylurea therapy augments basal and meal-stimulated insulin secretion while attenuating insulin responses to sulfonylurea per se.
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Kinetics; Middle Aged; Time Factors | 1992 |
Benefits and risks with glyburide and glipizide in elderly NIDDM patients.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Male | 1992 |
Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diet, Diabetic; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Tolbutamide | 1991 |
An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glipizide; Glyburide; Humans; Male; Middle Aged; Random Allocation; Sulfonylurea Compounds; Therapeutic Equivalency | 1990 |
Insulin and sulphonylurea in the therapy of type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Metformin; Middle Aged; Placebos; Random Allocation; Sulfonylurea Compounds | 1990 |
Comparison of secondary failure rate between three second generation sulphonylureas.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Follow-Up Studies; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Random Allocation | 1990 |
Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol Esters; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glucagon; Glucose Clamp Technique; Glyburide; Glycated Hemoglobin; Humans; Insulin; Lipoproteins; Male; Middle Aged; Sulfonylurea Compounds | 1990 |
Clinical comparison of glipizide and glyburide.
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Fasting; Glipizide; Glyburide; Humans; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1989 |
Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy.
Topics: Adult; Aged; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glipizide; Glyburide; Humans; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1988 |
Combination of two sulfonylureas. Does it make sense.
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glyburide; Glycated Hemoglobin; Glycosuria; Humans; Male; Middle Aged; Obesity; Sulfonylurea Compounds | 1988 |
Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Glycated Hemoglobin; Hepatitis B Surface Antigens; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sulfonylurea Compounds | 1988 |
Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
Topics: Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Erythrocytes; Female; Gastric Inhibitory Polypeptide; Glipizide; Glucagon; Glyburide; Glycosuria; Humans; Insulin; Insulin Resistance; Kinetics; Male; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.
Topics: Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Treatment Failure; Triglycerides | 1995 |
Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Time Factors | 1994 |
The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Stress, Physiological; Stress, Psychological; Surveys and Questionnaires | 1993 |
A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
Topics: Age Factors; Aged; Analysis of Variance; Blood Chemical Analysis; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Epinephrine; Fasting; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Peptides; Prospective Studies; Risk Factors | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Prospective Studies; Risk Factors; Sulfonylurea Compounds | 1998 |
Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glipizide; Glutathione; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Vitamin E | 2000 |
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Triglycerides | 2000 |
Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Postprandial Period; Prospective Studies; Therapeutic Equivalency; Time Factors; Treatment Outcome | 2000 |
Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetes.
Topics: Adult; Aged; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glucose Tolerance Test; Glyburide; Glycated Hemoglobin; Half-Life; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Proinsulin; White People | 2000 |
Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide.
Topics: Adult; Antibiotics, Antitubercular; Area Under Curve; Blood Glucose; Female; Glipizide; Glyburide; Half-Life; Humans; Hypoglycemic Agents; Male; Rifampin | 2001 |
Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal.
Topics: Aged; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Piperidines | 2002 |
Effects of sulfonylurea hypoglycemic agents and adenosine triphosphate dependent potassium channel antagonists on ventricular arrhythmias in patients with decompensated heart failure.
Topics: Aged; Analysis of Variance; Anti-Arrhythmia Agents; Chi-Square Distribution; Diabetes Complications; Diabetes Mellitus; Electrocardiography, Ambulatory; Female; Glipizide; Glyburide; Heart Failure; Humans; Hypoglycemic Agents; Male; Middle Aged; Potassium Channels; Regression Analysis; Sulfonylurea Compounds; Vasodilator Agents; Ventricular Fibrillation | 2003 |
145 other study(ies) available for glyburide and glipizide
| Article | Year |
|---|---|
Expedient synthesis and biochemical properties of an [125I]-labeled analogue of glyburide, a radioligand for ATP-inhibited potassium channels.
Topics: Adenosine Triphosphate; Animals; Brain; Cell Membrane; Glyburide; Iodine Radioisotopes; Male; Molecular Structure; Potassium Channels; Rats; Rats, Inbred Strains | 1990 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design.
Topics: Acids; Albumins; Drug Design; Humans; Hydrogen-Ion Concentration; Lipids; Molecular Structure; Pharmaceutical Preparations; Protein Binding | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Glipizide; Glyburide; Humans; Hydrogen-Ion Concentration; Sulfonylurea Compounds; Tolbutamide | 1979 |
Comparative study of the hypoglycaemic and antilipolytic effects of four antidiabetic agents administered i.v.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Injections, Intravenous; Male; Middle Aged; Sulfonamides; Thiadiazoles | 1976 |
Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
Topics: Animals; Glipizide; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Perfusion; Rats; Sulfonylurea Compounds; Tolbutamide | 1976 |
[Diabetes: new drugs?].
Topics: Biguanides; Diabetes Mellitus; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds | 1976 |
Circular dichroism studies on the interaction of sulfonylureas with bovine and human serum albumin.
Topics: Binding Sites; Binding, Competitive; Carbutamide; Chlorpropamide; Circular Dichroism; Glipizide; Glyburide; Humans; In Vitro Techniques; Optical Rotatory Dispersion; Protein Binding; Serum Albumin; Serum Albumin, Bovine; Sulfonylurea Compounds; Tolbutamide | 1976 |
Comparison of the pharmacokinetics of glipizide and glibenclamide in man.
Topics: Administration, Oral; Adult; Blood Glucose; Female; Glipizide; Glyburide; Half-Life; Humans; Injections, Intravenous; Insulin; Intestinal Absorption; Kinetics; Male; Sulfonylurea Compounds; Tablets | 1975 |
[Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
Topics: Administration, Oral; Ammonia; Animals; Dogs; Dose-Response Relationship, Drug; Female; Glipizide; Glyburide; Injections, Intravenous; Insulin; Islets of Langerhans; Mice; Purine-Pyrimidine Metabolism, Inborn Errors; Rats; Seizures; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1975 |
[Non-saturable cooperative binding of tolbutamide to rat endocrine pancreas. Criteria of specificity].
Topics: Animals; Diazoxide; Drug Interactions; Glipizide; Glucose; Glyburide; Islets of Langerhans; Kinetics; Rats; Tolbutamide | 1976 |
Effect of bed time intermediate acting insulin in NIDDM subjects refractory to a combination of sulphonylureas and biguanides.
Topics: Biguanides; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Injections, Subcutaneous; Insulin, Long-Acting; Lipids; Male; Metformin; Middle Aged; Phenformin; Sulfonylurea Compounds; Time Factors | 1992 |
Effects of drugs on ventricular fibrillation and ischaemic K+ loss in a model of ischaemia in perfused guinea-pig hearts in vitro.
Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Benzothiazoles; Calcium Channel Blockers; Disease Models, Animal; Glipizide; Glyburide; Guinea Pigs; In Vitro Techniques; Male; Myocardial Ischemia; Piperidines; Potassium; Potassium Channels; Pyrazines; Pyridines; Sympatholytics; Thiazoles; Ventricular Fibrillation | 1992 |
Specificity of photolabeling of beta-cell membrane proteins with an 125I-labeled glyburide analog.
Topics: Animals; Binding Sites; Cell Membrane; Chromatography, Gel; Cricetinae; Electrophoresis, Polyacrylamide Gel; Glipizide; Glyburide; Iodine Radioisotopes; Islets of Langerhans; Membrane Proteins; Photochemistry; Substrate Specificity; Tolbutamide; Tumor Cells, Cultured | 1992 |
K+ efflux pathways and neurotransmitter release associated to hippocampal ischemia: effects of glucose and of K+ channel blockers.
Topics: 4-Aminopyridine; Animals; Apamin; Aspartic Acid; Barium; Barium Compounds; Brain Ischemia; Calcium Chloride; Charybdotoxin; Chlorides; Elapid Venoms; gamma-Aminobutyric Acid; Glipizide; Glucose; Glyburide; Hippocampus; In Vitro Techniques; Kinetics; Potassium; Potassium Channels; Rats; Rats, Inbred Strains; Rubidium; Scorpion Venoms; Tetraethylammonium; Tetraethylammonium Compounds | 1991 |
Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: antagonism by sulfonylureas.
Topics: Adenosine Triphosphate; Animals; Dogs; Dose-Response Relationship, Drug; Female; Glipizide; Glyburide; Guanidines; Heart; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phenylephrine; Pinacidil; Potassium Channels; Purkinje Fibers; Rubidium Radioisotopes; Stereoisomerism; Sulfonylurea Compounds; Vasodilator Agents | 1991 |
RP 49356 and cromakalim relax airway smooth muscle in vitro by opening a sulphonylurea-sensitive K+ channel: a comparison with nifedipine.
Topics: Animals; Benzopyrans; Calcium; Cromakalim; Glipizide; Glyburide; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Nifedipine; Picolines; Potassium Channels; Pyrans; Pyrroles; Trachea | 1991 |
Quantitative autoradiography of the binding sites for [125I] iodoglyburide, a novel high-affinity ligand for ATP-sensitive potassium channels in rat brain.
Topics: Affinity Labels; Animals; Autoradiography; Binding Sites; Brain; Glipizide; Glyburide; Guanidines; Iodine Radioisotopes; Male; Pinacidil; Potassium Channels; Rats; Rats, Inbred Strains; Vasodilator Agents | 1991 |
Crossover comparison of maximum dose glyburide and glipizide.
Topics: Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glipizide; Glyburide; Humans; Lipoproteins; Male; Middle Aged; Triglycerides | 1991 |
[A comparison between glibenclamide and glipizide in the treatment of type II diabetes].
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation | 1991 |
Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds.
Topics: Animals; Arrhythmias, Cardiac; Blood Glucose; Carbutamide; Dose-Response Relationship, Drug; Electrocardiography; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Male; Myocardial Infarction; Potassium; Rats; Rats, Inbred Strains; Reference Values; Structure-Activity Relationship; Tolbutamide | 1990 |
A screening test for detecting sulfonylureas in plasma.
Topics: Aged; Aged, 80 and over; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Middle Aged; Sulfonylurea Compounds; Tolbutamide | 1990 |
Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Insulin Resistance; Middle Aged; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1990 |
Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells.
Topics: Adenosine Triphosphate; Animals; Benzamides; Diazoxide; Glipizide; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Ion Channels; Islets of Langerhans; Mice; Mice, Inbred Strains; Potassium; Sulfonylurea Compounds; Tolbutamide | 1988 |
Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Cromakalim; Drug Interactions; Glipizide; Glyburide; Guanidines; In Vitro Techniques; Male; Nifedipine; Norepinephrine; Pinacidil; Potassium Channels; Potassium Chloride; Pyrroles; Rabbits; Sulfonylurea Compounds; Tolbutamide; Vasodilator Agents | 1989 |
Glipizide and glyburide.
Topics: Diabetes Mellitus, Type 2; Drug Interactions; Glipizide; Glyburide; Humans; Kinetics; Sulfonylurea Compounds | 1986 |
Direct effects of sulfonylurea agents on glucose transport in the BC3H-1 myocyte.
Topics: Animals; Cell Line; Deoxy Sugars; Deoxyglucose; Glipizide; Glyburide; Hypoglycemic Agents; Insulin; Kinetics; Mice; Muscles; Tolbutamide | 1987 |
Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glipizide; Glucagon; Glucose; Glyburide; Humans; Hyperglycemia; Insulin; Insulin Secretion; Kinetics; Liver; Sulfonylurea Compounds | 1987 |
Characterization of the sulfonylurea receptor on beta cell membranes.
Topics: Animals; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Cricetinae; Glipizide; Glyburide; Insulin; Islets of Langerhans; Kinetics; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors; Temperature; Tolazamide; Tolbutamide | 1988 |
[Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Glipizide; Glyburide; Humans; Insulin Antibodies; Male; Middle Aged; Sulfonylurea Compounds; Time Factors | 1988 |
Glucose both inhibits and stimulates insulin secretion from isolated pancreatic islets exposed to maximally effective concentrations of sulfonylureas.
Topics: Animals; Cell Membrane; Glipizide; Glucose; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Iodine Radioisotopes; Islets of Langerhans; Keto Acids; Male; Mice; Sulfonylurea Compounds | 1988 |
Reversal of insulin resistance in adipose tissue of non-insulin-dependent diabetics by treatment with diet and sulphonylurea.
Topics: Adipose Tissue; Diabetes Mellitus, Type 2; Female; Glipizide; Glucose; Glyburide; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Oxidation-Reduction; Receptor, Insulin; Sulfonylurea Compounds | 1985 |
Pharmacokinetics of glyburide.
Topics: Acute Kidney Injury; Blood Glucose; Dose-Response Relationship, Drug; Fasting; Glipizide; Glyburide; Humans; Kidney; Kinetics; Liver | 1985 |
The second generation sulfonylureas: glipizide and glyburide.
Topics: Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Insulin; Sulfonylurea Compounds | 1985 |
Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets.
Topics: Animals; Carbutamide; Chlorpropamide; Glipizide; Glyburide; Islets of Langerhans; Mice; Mice, Obese; Sulfonylurea Compounds; Tolbutamide | 1984 |
Clinical pharmacology of glipizide.
Topics: Biological Availability; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Half-Life; Humans; Kinetics; Structure-Activity Relationship; Sulfonylurea Compounds; Tolbutamide | 1983 |
Effect of sulfonylurea on glucose, insulin and C-peptide responses to a meal stimulus in a patient with type 2 diabetes and liver disease.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Food; Glipizide; Glyburide; Humans; Insulin; Liver Diseases; Liver Neoplasms; Sulfonylurea Compounds | 1984 |
Glyburide and glipizide.
Topics: Diabetes Mellitus; Glipizide; Glyburide; Humans; Sulfonylurea Compounds | 1984 |
The new oral antidiabetic drugs.
Topics: Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Sulfonylurea Compounds | 1984 |
The effect of improvement in diabetic control on plasma and whole blood viscosity.
Topics: Adolescent; Adult; Blood; Blood Glucose; Diabetes Mellitus; Female; Glipizide; Glyburide; Hemoglobin A; Humans; Insulin; Male; Middle Aged; Plasma; Viscosity | 1980 |
Glipizide: experimental study and comparison with other sulfonylureas.
Topics: Animals; Blood Glucose; Dogs; Dose-Response Relationship, Drug; Glipizide; Glyburide; Hypoglycemia; Insulin; Islets of Langerhans; Mice; Rats; Sulfonylurea Compounds; Tolbutamide | 1980 |
Kinetics-effect relations of glipizide and other sulfonylureas.
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus; Dose-Response Relationship, Drug; Fasting; Feeding Behavior; Glipizide; Glyburide; Humans; Kidney; Sulfonylurea Compounds; Tolbutamide | 1980 |
Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
Topics: Aged; Blood Glucose; Circadian Rhythm; Diabetes Mellitus; Female; Glipizide; Glyburide; Humans; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1980 |
Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
Topics: Adult; Blood Glucose; Chlorpropamide; Fasting; Glipizide; Glyburide; Humans; Insulin; Kinetics; Male; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1980 |
Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma.
Topics: Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drug Monitoring; Forensic Medicine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Reproducibility of Results; Sensitivity and Specificity; Sulfonylurea Compounds | 1995 |
Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages.
Topics: Adult; Animals; Cells, Cultured; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Humans; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Middle Aged; Muscle, Smooth, Vascular; Sulfonylurea Compounds; Tunica Intima | 1994 |
Photoaffinity labeling of the cerebral sulfonylurea receptor using a novel radioiodinated azidoglibenclamide analogue.
Topics: Affinity Labels; Animals; ATP-Binding Cassette Transporters; Binding, Competitive; Cell Fractionation; Cerebral Cortex; Electrophoresis, Polyacrylamide Gel; Glipizide; Glyburide; Iodine Radioisotopes; Kinetics; Microsomes; Molecular Weight; Photolysis; Potassium Channels; Potassium Channels, Inwardly Rectifying; Radioligand Assay; Receptors, Drug; Sulfonylurea Receptors; Swine; Tolbutamide; Tritium | 1994 |
Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer.
Topics: Administration, Oral; Analysis of Variance; Antipyrine; Biological Transport; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Maternal-Fetal Exchange; Models, Biological; Molecular Weight; Placenta; Pregnancy; Regression Analysis; Tolbutamide | 1994 |
K(+)-channel blockers and coronary vasoconstriction in guinea-pig perfused hearts in-vitro.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Animals; Coronary Vessels; Glipizide; Glyburide; Guinea Pigs; In Vitro Techniques; Male; Perfusion; Phentolamine; Potassium Channels; Pyrazines; Pyridines; Vasoconstriction | 1993 |
Effects of antidiabetic sulphonylureas, cromakalim and their interaction in guinea-pig isolated tracheal smooth muscle.
Topics: Animals; Benzopyrans; Cromakalim; Drug Interactions; Glipizide; Glyburide; Guinea Pigs; Hypoglycemic Agents; Muscle Relaxation; Muscle, Smooth; Potassium Channels; Pyrroles; Sulfonylurea Compounds; Trachea | 1993 |
ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Affinity Labels; Animals; Calcium; Cells, Cultured; Diazoxide; Female; Glipizide; Glyburide; Growth Hormone; Hypoglycemic Agents; Kinetics; Membrane Potentials; Oligomycins; Pituitary Gland, Anterior; Potassium Channels; Rats; Receptors, Drug; Sulfonylurea Compounds | 1993 |
Alteration of rat hepatic insulin metabolism by glyburide and glipizide.
Topics: Animals; Glipizide; Glyburide; In Vitro Techniques; Insulin; Liver; Male; Perfusion; Rats; Rats, Sprague-Dawley | 1993 |
Bedtime insulin added to daytime sulfonylureas improves glycemic control in uncontrolled type II diabetes.
Topics: Adult; Aged; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glipizide; Glyburide; Humans; Insulin, Isophane; Middle Aged; Obesity; Prospective Studies; Time Factors | 1993 |
Disturbances in autoregulatory responses of rat pial arteries by sulfonylureas.
Topics: Animals; Arterioles; Blood Pressure; Cerebral Arteries; Glipizide; Glyburide; Pia Mater; Rats; Rats, Sprague-Dawley; Vasodilation | 1993 |
PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells.
Topics: Animals; Calcium; Cells, Cultured; Cytoplasmic Granules; Electric Conductivity; Exocytosis; Glipizide; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Mice; Patch-Clamp Techniques; Protein Kinase C; Sulfonylurea Compounds; Tolbutamide | 1996 |
Detection of hypoglycemic drugs in human urine using micellar electrokinetic chromatography.
Topics: Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Micelles; Reproducibility of Results; Sulfonylurea Compounds | 1995 |
Gliclazide hydroxylation by rat liver microsomes.
Topics: Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gliclazide; Glipizide; Glyburide; Hydroxylation; Hypoglycemic Agents; Kinetics; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley; Tolbutamide | 1995 |
Sulfonylureas enhance GABAA synaptic potentials in rat midbrain dopamine neurones.
Topics: Animals; Dopamine; Electric Stimulation; Glipizide; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Male; Membrane Potentials; Mesencephalon; Neurons; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Sulfonylurea Compounds; Synapses | 1996 |
Photodegradation products of sulphonamide-derived oral antidiabetics and diuretics are not phototoxic in vitro.
Topics: Bendroflumethiazide; Dermatitis, Phototoxic; Diuretics; Furosemide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Photochemistry; Photosensitizing Agents; Sulfonamides; Tumor Cells, Cultured | 1996 |
The effect of pH on the in-vitro dissolution of three second-generation sulphonylurea preparations: mechanism of antacid-sulphonylurea interaction.
Topics: Antacids; Glipizide; Glyburide; Hydrogen-Ion Concentration; Hypoglycemic Agents; Solubility; Tablets | 1996 |
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E | 1996 |
Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited.
Topics: Administration, Oral; Aged; Diabetes Mellitus; Female; Glipizide; Glyburide; Heart Atria; Humans; Hypoglycemic Agents; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardial Contraction; Potassium Channels; Sulfonylurea Compounds | 1997 |
Rates of hypoglycemia in users of sulfonylureas.
Topics: Adult; Aged; Chlorpropamide; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Poisson Distribution; Risk; Risk Factors; Sulfonylurea Compounds; Surveys and Questionnaires; Time Factors; Tolbutamide | 1997 |
Prospective multicenter study of sulfonylurea ingestion in children.
Topics: Accidents; Administration, Oral; Blood Glucose; Body Weight; Child; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Drug Monitoring; Female; Forecasting; Gastrointestinal Agents; Glipizide; Glucagon; Glucose; Glyburide; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Infant; Infusions, Intravenous; Male; Patient Admission; Poison Control Centers; Prospective Studies; Risk Factors; Sensitivity and Specificity; Sulfonylurea Compounds; Time Factors; Treatment Outcome | 1997 |
Capillary electrophoretic detection of metabolites in the urine of patients receiving hypoglycemic drug therapy.
Topics: Electrophoresis, Capillary; Glipizide; Glyburide; Humans; Hypoglycemia; Sulfonylurea Compounds | 1997 |
A retrospective analysis of the efficacy and safety of metformin in the African-American patient.
Topics: Adult; Aged; Aged, 80 and over; Black People; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin, Isophane; Male; Metformin; Middle Aged; Prognosis; Retrospective Studies | 1997 |
Pharmacological and biochemical evidence for the regulation of osteocalcin secretion by potassium channels in human osteoblast-like MG-63 cells.
Topics: Adenosine Triphosphate; Antihypertensive Agents; Blotting, Western; Calcium Channel Blockers; Calcium Channels; Diazoxide; Dose-Response Relationship, Drug; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Osteoblasts; Osteocalcin; Osteosarcoma; Potassium Channels; Tumor Cells, Cultured | 1997 |
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Sulfonylurea Compounds; Tolbutamide | 1997 |
Whole cell patch-clamp recordings of rat midbrain dopaminergic neurons isolate a sulphonylurea- and ATP-sensitive component of potassium currents activated by hypoxia.
Topics: Adenosine Triphosphate; Animals; Barium Compounds; Cell Hypoxia; Charybdotoxin; Chlorides; Dopamine; Glipizide; Glyburide; In Vitro Techniques; Membrane Potentials; Mesencephalon; Microelectrodes; Neurons; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Wistar; Reaction Time; Sulfonylurea Compounds; Tolbutamide | 1998 |
Hypoglycemia from glipizide and glyburide.
Topics: Glipizide; Glyburide; Humans; Hypoglycemia; Risk | 1998 |
Hypoglycemia from glipizide and glyburide.
Topics: Aged; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Hypoglycemia; Risk | 1998 |
Formulary conversion from glipizide to glyburide: a cost-minimization analysis.
Topics: Aged; Cost Savings; Drug Costs; Formularies, Hospital as Topic; Glipizide; Glyburide; Hospitals, Municipal; Humans; Hypoglycemic Agents; New York City; Pharmacy Service, Hospital | 1995 |
Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
Topics: Animals; ATP-Binding Cassette Transporters; Binding Sites; Blotting, Northern; Cell Line; Cell Membrane; COS Cells; Gliclazide; Glipizide; Glyburide; Islets of Langerhans; Kinetics; Organelles; Phentolamine; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Recombinant Fusion Proteins; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide; Transfection | 1999 |
[Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Factors | 1999 |
Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues.
Topics: Animals; Antioxidants; Brain; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Hypoglycemic Agents; Kidney; Liver; Lung; Male; Malondialdehyde; Myocardium; Rats | 1999 |
Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects.
Topics: Aged; Female; Gliclazide; Glipizide; Glyburide; Half-Life; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds | 1999 |
Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.
Topics: ATP-Binding Cassette Transporters; Binding, Competitive; Cations; Cell Line; Deoxyglucose; Diazoxide; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Fluorescence; Gene Expression; Glipizide; Glyburide; Humans; Membrane Potentials; Oligomycins; Potassium Channels; Potassium Channels, Inwardly Rectifying; Radioligand Assay; Receptors, Drug; Recombinant Fusion Proteins; RNA, Messenger; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolazamide; Tolbutamide; Tritium | 2000 |
Identification of sulfonylureas in serum by electrospray mass spectrometry.
Topics: Calibration; Chlorpropamide; Chromatography, Liquid; Glipizide; Glyburide; Humans; Mass Spectrometry; Models, Chemical; Sulfonylurea Compounds; Tolbutamide; Ultraviolet Rays | 2000 |
Acidic dopamine metabolites are actively extruded from PC12 cells by a novel sulfonylurea-sensitive transporter.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3T3 Cells; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport, Active; Dopamine; Glipizide; Glyburide; Homovanillic Acid; Male; Mice; Microdialysis; Multidrug Resistance-Associated Proteins; PC12 Cells; Potassium Channels; Potassium Channels, Inwardly Rectifying; Probenecid; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Drug; Rhodamines; RNA, Messenger; Sulfonylurea Receptors; Transfection | 2000 |
Differences in pharmacotherapy and in glucose control of type 2 diabetes patients in two neighbouring towns: a longitudinal population-based study.
Topics: Aged; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Longitudinal Studies; Male; Retrospective Studies; Sweden; Time Factors; Urban Population | 2001 |
Severe hypoglycemia from clarithromycin-sulfonylurea drug interaction.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male | 2002 |
The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels.
Topics: 4-Aminopyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apamin; ATP-Binding Cassette Transporters; Charybdotoxin; Female; Glipizide; Glyburide; KATP Channels; Morphine; Narcotics; Peripheral Nervous System; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Resveratrol; Stilbenes; Tetraethylammonium; Tolbutamide | 2002 |
Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin.
Topics: Administration, Cutaneous; Animals; Chemical Phenomena; Chemistry, Physical; Glipizide; Glyburide; Hypoglycemic Agents; Mice; Skin Absorption; Solubility | 2002 |
Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.
Topics: Carbamates; Cohort Studies; Decision Trees; Diabetes Mellitus, Type 2; Direct Service Costs; Drug Costs; Drug Therapy, Combination; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Managed Care Programs; Markov Chains; Metformin; Models, Economic; Piperidines; Rosiglitazone; Thiazoles; Thiazolidinediones; United States | 2003 |
Effect of some penetration enhancers on the permeation of glibenclamide and glipizide through mouse skin.
Topics: Animals; Ethanol; Excipients; Glipizide; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Mice; Skin Absorption; Solubility; Solvents | 2003 |
The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or glimperide in plasma.
Topics: Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metformin; Reference Standards; Sensitivity and Specificity | 2005 |
Antidiabetic sulphonylureas activate mitochondrial permeability transition in rat skeletal muscle.
Topics: Animals; Calcium; Cyclosporine; Glipizide; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Membrane Potentials; Mitochondria, Muscle; Mitochondrial Swelling; Muscle, Skeletal; Oxygen; Permeability; Rats; Sulfonylurea Compounds | 2005 |
Transfer of glyburide and glipizide into breast milk.
Topics: Adult; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Infant; Infant Food; Milk, Human | 2005 |
The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbits.
Topics: Animals; Glipizide; Glyburide; Heart; Hypnotics and Sedatives; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Ischemic Preconditioning, Myocardial; Ketamine; Male; Models, Animal; Myocardial Infarction; Rabbits; Xylazine | 2005 |
Simultaneous estimation of six anti-diabetic drugs--glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human p
Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Molecular Structure; Pioglitazone; Piperidines; Reproducibility of Results; Rosiglitazone; Thiazolidinediones | 2006 |
Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs.
Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Molecular Structure; Piperidines; Reproducibility of Results; Sulfonylurea Compounds | 2007 |
Sitagliptin: new drug. Type 2 diabetes: limited efficacy, too many unknown risks.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Europe; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Pyrazines; Triazoles | 2008 |
Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; France; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Quality of Life; Stress, Psychological; Sulfonylurea Compounds | 2008 |
Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study.
Topics: Adult; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Risk; Sulfonylurea Compounds | 2008 |
Comparison of ultraviolet detection, evaporative light scattering detection and charged aerosol detection methods for liquid-chromatographic determination of anti-diabetic drugs.
Topics: Aerosols; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Light; Reproducibility of Results; Scattering, Radiation; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds | 2010 |
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Sulfonylurea Compounds | 2010 |
Effect of sulfonylurea dose escalation on hemoglobin A1c in Veterans Affairs patients with type 2 diabetes.
Topics: Aged; Creatinine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Retrospective Studies; United States; United States Department of Veterans Affairs; Veterans | 2013 |
Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Blood Glucose; Case-Control Studies; Cross-Over Studies; Cytochrome P-450 CYP2C9; Drug Interactions; Enzyme Inhibitors; Ethnicity; Female; Fluconazole; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Risk; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2010 |
Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glipizide; Glyburide; Hospitalization; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds; Young Adult | 2010 |
Quantitative insulin and C-peptide levels among ED patients with sulfonylurea-induced hypoglycemia-a prospective case series.
Topics: Aged; Aged, 80 and over; C-Peptide; Cross-Sectional Studies; Drug Overdose; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Prospective Studies; Sulfonylurea Compounds | 2010 |
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry.
Topics: Aged; Asian People; Cohort Studies; Diabetes Mellitus, Type 2; Female; Gliclazide; Glipizide; Glyburide; Hong Kong; Humans; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Prospective Studies; Registries; Risk Factors; Sulfonylurea Compounds | 2010 |
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Female; Glipizide; Glyburide; Heart Failure; Humans; Hypoglycemic Agents; Male; Sulfonylurea Compounds; Tolbutamide | 2011 |
Hypoglycemia after accidental pediatric sulfonylurea ingestions.
Topics: Accidents, Home; Arizona; Blood Glucose; Child, Preschool; Emergency Service, Hospital; Glipizide; Glucose; Glyburide; Hospitals, Pediatric; Hospitals, Teaching; Hospitals, Urban; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Infant; Poisoning; Retrospective Studies; Sulfonylurea Compounds; Time Factors | 2011 |
Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide.
Topics: Aged; Blood Glucose; Creatinine; Diabetes Mellitus; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; United States; United States Department of Veterans Affairs | 2011 |
Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers.
Topics: Alanine; Amino Acid Sequence; Animals; Benzamides; Cystic Fibrosis Transmembrane Conductance Regulator; Glipizide; Glyburide; Ion Channel Gating; Kinetics; Mutagenesis; Oocytes; Patch-Clamp Techniques; Sulfonylurea Compounds; Tolbutamide; Xenopus | 2012 |
The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
Topics: Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Retrospective Studies; Risk Factors; Sulfonylurea Compounds | 2012 |
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Propensity Score; Retrospective Studies; Sulfonylurea Compounds; Young Adult | 2012 |
Hypoglycemia in hospitalized patients treated with sulfonylureas.
Topics: Academic Medical Centers; Age Factors; Aged; Blood Glucose; Case-Control Studies; Drug Therapy, Combination; Female; Glipizide; Glomerular Filtration Rate; Glyburide; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Multivariate Analysis; Regression Analysis; Retrospective Studies; Risk Factors; Sulfonylurea Compounds | 2012 |
Rapid extraction, identification and quantification of oral hypoglycaemic drugs in serum and hair using LC-MS/MS.
Topics: Acetonitriles; Chromatography, Liquid; Female; Forensic Toxicology; Gliclazide; Glipizide; Glyburide; Hair; Humans; Hypoglycemic Agents; Limit of Detection; Male; Mass Spectrometry; Metformin; Methanol; Middle Aged; Molecular Structure; Solvents; Sulfonylurea Compounds | 2012 |
Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone.
Topics: Adrenergic beta-Antagonists; Amino Acid Sequence; Anti-Infective Agents; Catalytic Domain; Crystallography, X-Ray; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metipranolol; Models, Molecular; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Pioglitazone; Quantitative Structure-Activity Relationship; ROC Curve; Sequence Alignment; Sotalol; Sulfamethizole; Thiazolidinediones; TOR Serine-Threonine Kinases | 2013 |
Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy.
Topics: Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; United States; Veterans | 2013 |
Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Case-Control Studies; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Female; Fibric Acids; Glipizide; Glyburide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Pharmacoepidemiology; Sulfonylurea Compounds; Young Adult | 2014 |
Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
Topics: Animals; Blood Glucose; CA3 Region, Hippocampal; Cell Death; Glipizide; Glyburide; Hyperglycemia; Hypoglycemic Agents; Infusions, Intraventricular; Kainic Acid; Male; Mice; Mice, Inbred ICR; Neurons; Sulfonylurea Compounds; Tolbutamide | 2014 |
Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cohort Studies; Diabetes Mellitus; Drug Interactions; Emergency Service, Hospital; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Medicare; Polypharmacy; Primary Health Care; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2015 |
Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Drug Prescriptions; Female; Glipizide; Glyburide; Health Care Costs; Humans; Hypoglycemia; Hypoglycemic Agents; Levofloxacin; Logistic Models; Male; Medicare; Metronidazole; Morbidity; Odds Ratio; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; Texas; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2014 |
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
Topics: Aged; Carbamates; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Morbidity; Myocardial Infarction; Piperidines; Registries; Retrospective Studies; Risk Factors; Stroke; Sulfonylurea Compounds; Tolbutamide | 2015 |
Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.
Topics: Aged; Algorithms; Cohort Studies; Drug Interactions; Female; Fenofibrate; Glipizide; Glyburide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Incidence; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Sulfonylurea Compounds | 2016 |
Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.
Topics: Area Under Curve; Carbamates; Cyclohexanes; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Medical Informatics; Nateglinide; Pharmacoepidemiology; Phenylalanine; Piperidines; Sulfonylurea Compounds | 2017 |
Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways.
Topics: Calorimetry, Differential Scanning; Crystallization; Drug Compounding; Drug Liberation; Drug Stability; Glipizide; Glyburide; Hydrogen Bonding; Hypromellose Derivatives; Indapamide; Metolazone; Molecular Dynamics Simulation; Povidone; Spectrum Analysis, Raman | 2017 |
Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.
Topics: Adult; Aged; Cohort Studies; Diabetes Mellitus, Type 2; Emergency Service, Hospital; Female; Glipizide; Glyburide; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Sentinel Surveillance; Severity of Illness Index; United States | 2017 |
Risk of Hypoglycemia Following Hospital Discharge in Patients With Diabetes and Acute Kidney Injury.
Topics: Acute Kidney Injury; Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Nephropathies; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Kidney Function Tests; Male; Middle Aged; Patient Discharge; Retrospective Studies; Risk Factors | 2018 |
Effect of Tinospora cordifolia aqua-alcoholic extract on pharmacokinetic of Glibenclamide in rat: An herb-drug interaction study.
Topics: Administration, Oral; Animals; Biological Availability; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Ethanol; Glipizide; Glyburide; Herb-Drug Interactions; Humans; Isoenzymes; Male; Metabolic Clearance Rate; Microsomes, Liver; Plant Extracts; Rats; Rats, Sprague-Dawley; Reference Standards; Tinospora; Water | 2018 |
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.
Topics: Aged; Arrhythmias, Cardiac; Cause of Death; Death, Sudden, Cardiac; Diabetic Angiopathies; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; United States; Ventricular Dysfunction | 2018 |
Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis.
Topics: Aged; Carbamates; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Mortality; Piperidines; Secretagogues; Sulfonylurea Compounds; Taiwan | 2019 |
Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling.
Topics: Chagas Disease; Computer Simulation; Drug Repositioning; Folic Acid Antagonists; Glipizide; Glyburide; Humans; Ligands; Molecular Docking Simulation; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Sulfonylurea Compounds; Trypanocidal Agents; Trypanosoma cruzi | 2020 |
Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations.
Topics: Aged; Cohort Studies; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Male; Medicaid; Middle Aged; Sulfonylurea Compounds; Treatment Outcome; United States; Ventricular Fibrillation | 2020 |
Sensitive detection of antidiabetic compounds and one degradation product in wastewater samples by a new SPE-LC-MS/MS method.
Topics: Chromatography, Liquid; Environmental Monitoring; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Metformin; Reproducibility of Results; Solid Phase Extraction; Sulfonylurea Compounds; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2021 |
Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia.
Topics: Administrative Claims, Healthcare; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Carbamates; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Medicaid; Metformin; Middle Aged; Nateglinide; Pharmacoepidemiology; Piperidines; Secretagogues; Sulfonylurea Compounds; United States | 2022 |
Total Synthesis of Glipizide and Glibenclamide in Continuous Flow.
Topics: Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin | 2021 |
Comparative safety of sulfonylureas among U.S. nursing home residents.
Topics: Aged; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Medicare; Myocardial Infarction; Nursing Homes; Retrospective Studies; Stroke; United States | 2023 |
Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Metformin; Nitrosamines; Pharmaceutical Preparations; Tandem Mass Spectrometry | 2023 |
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide | 2024 |